Lonza
Lonza to Divest Peptides Business to PolyPeptide
Lonza (Switzerland) and the PolyPeptide Group (Belgium) jointly announced that PolyPeptide Laboratories Holding (PPL) AB has entered into a definitive agreement with Lonza Sales AG and Lonza AG (both 100 percent affiliates of Lonza Group AG) to acquire the peptides business and operations of Lonza in Braine-l’Alleud, Belgium. Lonza’s Braine facility, with approximately 280 employees, ...
Lonza Acquires InterHealth Nutraceuticals
Lonza (Basel, Switzerland) has announced that it has agreed to acquire California-based InterHealth Nutraceuticals, Inc., a leader in research, development, manufacture and marketing of value-added nutritional ingredients for use in dietary supplements, based in Benicia, CA (USA). InterHealth is a portfolio company of Kainos Capital. “With this acquisition Lonza is taking a further step along ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
